Treatment of Cytomegalovirus Retinitis With an Intraocular Sustained-Release Ganciclovir Implant: A Randomized Controlled Clinical Trial

Archives of Ophthalmology

Volumn 112, Issue 12, 1994, Pages 1531-1539

  Martin, Daniel F ^a,b   Parks, David J ^a   Mellow, Susan D ^a   Ferris, Frederick L ^a   Walton, R Christopher ^a   Remaley, Nancy A ^a   Chew, Emily Y ^a   Ashton, Paul ^c,e   Davis, Matthew D ^d   Nussenblatt, Robert B ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW ENGLAND EYE CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e ganciclovir implant ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG EFFICACY; DRUG IMPLANT; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; IMPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA TEAR; RETINITIS; SURVIVAL; SUSTAINED RELEASE PREPARATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIAS (EPIDEMIOLOGY); CYTOMEGALOVIRUS RETINITIS; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMAN; MALE; MIDDLE AGE; RETINAL PERFORATIONS;

EID: 0027937920     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1994.01090240037023     Document Type: Article

References (40)

1. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD. Roos RY. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983;90:859-873.
2. Friedman AH, Orellana J, Freeman WR, et al. Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol. 1983;67:372-380.
3. Freeman WR, Lerner CW, Mines JA, et al. A prospective study of the ophthalmologic findings in the acquired immunodeficiency syndrome. Am J Ophthalmol. 1984;97:133-142.
4. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:75-80.
5. Gross JG, Bozzette SA, Mathews WC, et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990;97:681-686.
6. Palestine AG, Rodrigues MM, Macher AM, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;91:1092-1099.
7. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med. 1993;329:1922-1926.
8. Kuppermann BD, Petty JG, Richman DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
9. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, and the Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 1992;166:1223-1227.
10. Palestine A, Stevens G, Lane HC, et al. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol. 1986;101:95-101.
11. Collaborative DHPG Treatment Study Group. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med. 1986;314:801-805.
12. Henderly DE, Freeman WR, Causey DM, Rao NA. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology. 1987;94:425-434.
13. Holland GN, Sidikaro Y, Kreiger AE,et al. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology. 1987;94:815-822.
14. Jabs DA, Newman C, DeBustros S, Polk BF. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987;94:824-830.
15. Orellana J, Teich SA, Friedman AH, Lerebours F, Winterkorn J, Mildvan D. Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). Ophthalmology. 1987;94:831-838.
16. Buhles WC Jr, Mastre BJ, Tinker AJ, et al. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988;10(suppl 3):495-506.
17. Palestine AG, Polis MA, de Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991;115:665-673.
18. Walmsley SL, Chew E, Read SE, et al. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet). J Infect Dis. 1988;157:569-572.
19. Le Hoang P, Girard B, Robinet M, et al. Foscarnet in the treatment of cytomegalovirus in acquired immune deficiency syndrome. Ophthalmology. 1989;96:865-874.
20. Fanning MM, Read SE, Benson M, et al. Foscarnet therapy of cytomegalovirus retinitis in AIDS. J Acquir Immune Defic Syndr. 1990;3:472-479.
21. Jacobson MA, O'Donnell JJ, Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1989;33:736-741.
22. Studies of the Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
23. Studies of the Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial, 4: visual outcomes. Ophthalmology. 1994;101:1250-1261.
24. Henry K, Cantrill HL, Fletcher C, et al. Use of intravitreal ganciclovir (dihydroxypropoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol. 1987;103:17-23.
25. Ussery FM III, Gibson SR, Conklin RH, et al. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology. 1988;95:640-648.
26. Cantrill HL, Henry K, Melroe NH, et al. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results. Ophthalmology. 1989;96:367-374.
27. Heinemann M-H. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1989;107:1767-1772.
28. Cochereau-Massin I, Le Hoang P, Lautier-Frau M, et al. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1991;98:1348-1353.
29. Smith TJ, Pearson PA, Blandford DL, et al. Intravitreal sustained-release ganciclovir. Arch Ophthalmol. 1992;110:255-258.
30. Sanborn GE, Anand R, Torti RE, et al. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis: use of an intravitreal device. Arch Ophthalmol. 1992;110:188-195.
31. Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993;111:223-227.
32. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
33. Kuppermann BD, Quiceno JI, Flores-Aguilar M, et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis. 1993;168:1506-1509.
34. Jabs DA, Enger C, Haller J, de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991;109:794-799.
35. Freeman WR, Friedberg DN, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116:713-720.
36. Dugel PU, Liggett PE, Lee MB, et al. Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1991;112:235-242.
37. Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Flores-Aguilar M. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992;99:466-474.
38. Kupperman BD, Flores-Aguilar M, Quiceno JI, et al. A masked prospective evaluation of outcome parameters for cytomegalovirus-related retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology. 1994;101:46-55.
39. McKenzie R, Travis WD, Dolan S, et al. The causes of death in patients with human immunodeficiency virus infection: a clinical pathological study with emphasis on the role of pulmonary diseases. Medicine. 1991;70:326-343.
40. Polis MA, de Smet MD, Baird BF, et al. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Am J Med. 1993;94:175-180.